Marshall Wace North America’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $114M | Buy |
188,467
+129,839
| +221% | +$78.6M | 0.49% | 40 |
|
|
2021
Q2 | $32.7M | Buy |
58,628
+45,916
| +361% | +$25.6M | 0.14% | 154 |
|
|
2021
Q1 | $6.02M | Buy |
12,712
+10,374
| +444% | +$4.91M | 0.02% | 513 |
|
|
2020
Q4 | $1.13M | Buy |
+2,338
| New | +$1.13M | 0.01% | 910 |
|
|
2020
Q3 | – | Sell |
-54,475
| Closed | -$34M | – | 1430 |
|
|
2020
Q2 | $34M | Buy |
54,475
+43,413
| +392% | +$27.1M | 0.22% | 113 |
|
|
2020
Q1 | $5.4M | Buy |
11,062
+8,433
| +321% | +$4.12M | 0.04% | 303 |
|
|
2019
Q4 | $987K | Buy |
+2,629
| New | +$987K | ﹤0.01% | 716 |
|
|
2019
Q1 | – | Sell |
-131
| Closed | -$49K | – | 1842 |
|
|
2018
Q4 | $49K | Buy |
+131
| New | +$49K | ﹤0.01% | 1257 |
|
|
2018
Q3 | – | Sell |
-14,764
| Closed | -$5.09M | – | 1290 |
|
|
2018
Q2 | $5.09M | Buy |
14,764
+5,386
| +57% | +$1.86M | 0.03% | 502 |
|
|
2018
Q1 | $3.23M | Buy |
+9,378
| New | +$3.23M | 0.02% | 674 |
|
|
2017
Q2 | – | Sell |
-1,977
| Closed | -$767K | – | 1433 |
|
|
2017
Q1 | $767K | Buy |
+1,977
| New | +$767K | 0.01% | 745 |
|
|
2013
Q4 | $9.84M | Buy |
+35,766
| New | +$9.84M | 0.21% | 115 |
|